Managing seborrheic keratosis: Evolving strategies and optimal therapeutic outcomes

Stephanie Kao, Alexi Kiss, Tatiana Efimova, Adam J. Friedman*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Seborrheic keratosis (SK) is the most common skin tumor seen by dermatologists in everyday practice. Although the lesions are mostly benign, many patients still elect to have asymptomatic SK removed. The historical standards of treatment are cryosurgery and electrocautery, two surgical options that are effective at lesion removal but have high rates of postoperative adverse events such as treatment-site scarring and pigmentary alterations. The cosmetic outcomes of SK treatment modalities are of keen interest to dermatologists, as the American population becomes increasingly more diverse. In this article, the inclusion of darker Fitzpatrick skin types into clinical studies investigating post-treatment side effects of SK therapy is reviewed. The recent approval of a 40% hydrogen peroxide topical formulation is discussed in light of these issues, and several non-invasive topical treatments that optimize cosmetic outcomes of SK lesion removal are highlighted. Finally, treatment strategies aimed at reducing cost and minimizing the burden of adverse sequelae are provided.

Original languageEnglish (US)
Pages (from-to)931-940
Number of pages10
JournalJournal of Drugs in Dermatology
Volume17
Issue number9
StatePublished - Sep 2018

Funding

Disclosure of Commercial Support: This activity is supported by an educational grant provided by Aclaris Therapeutics Inc.

ASJC Scopus subject areas

  • Dermatology

Fingerprint

Dive into the research topics of 'Managing seborrheic keratosis: Evolving strategies and optimal therapeutic outcomes'. Together they form a unique fingerprint.

Cite this